CONVERIDE

150MG/12,5MG TBL FLM 30 I

SÚKL code 0197486
Name of the product CONVERIDE
_MA_MEDICATION_DETAIL_INFO_MED_NAME i CONVERIDE
Supplement 150MG/12,5MG TBL FLM 30 I
Strenght 150MG/12,5MG
Pharmaceutical form Film-coated tablet
Package 30 I
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDUM)
IRBESARTAN (IRBESARTANUM)
ATC group C09DA04
ATC group name IRBESARTAN A DIURETIKA
Doping Diuretika a ostatní maskovací látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/.

Marketing authorisation information

Registration Number 58/ 256/14-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 05. 2020
MA Holder MEDOPHARM, s.r.o., Praha
MA Holder country ČESKÁ REPUBLIKA
Actual MA holder Medochemie Ltd., Limassol
Actual MA holder country KYPR

Back to list